![](/img/cover-not-exists.png)
Updated survival analysis of the randomized phase III trial comparing S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer (SALTO) by the Dutch Colorectal Cancer Group
Kwakman, J.J.M., van Werkhoven, E., Simkens, L.H.J., van Rooijen, J.M., van de Wouw, A.J., ten Tije, A.J., Creemers, G.J.M., Hendriks, M.P., Los, M., van Alphen, R.J., Polée, M.B., Muller, E.W., van dLanguage:
english
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2019.01.002
Date:
January, 2019
File:
PDF, 737 KB
english, 2019